Watch live: Biden speaks about fight against Covid as more contagious omicron BA.2 gains ground

Watch live: Biden speaks about fight against Covid as more contagious omicron BA.2 gains ground


[The stream is slated to start at 1:30 p.m. ET. Please refresh the page if you do not see a player above at that time.]

President Joe Biden is set to give a speech Wednesday about the fight against Covid-19 in the U.S.

The president’s remarks come a day after the Centers for Disease Control and Prevention recommended a fourth Covid vaccine shot of Pfizer or Moderna for people ages 50 or older. The CDC also recommended that certain younger people with compromised immune systems should receive a fifth of dose.

Biden will receive his fourth dose after his speech, according to the White House.

Congress is also fumbling billions of dollars in Covid funding as a more contagious subvariant of omicron, BA.2, takes hold across the country. BA.2 has caused new outbreaks in Europe and China, though White House chief medical advisor Dr. Anthony Fauci has said he does not expect another surge here.

However, the Biden administration has warned Congress that failing to pass $22.5 billion in new Covid money will result in drastic cuts to the nation’s pandemic response plan, leaving the nation unprepared if another surge takes places.

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:



Source

Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here
Health

Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here

Wall Street is optimistic that Olema Pharmaceutical could be developing the next major breakthrough breast cancer treatment. Earlier this month, the company announced promising clinical data for its lead candidate palazestrant, an oral medication that is being evaluated in several trials for estrogen receptor-positive, or ER+, breast cancer. Shares of the clinical-stage biopharmaceutical company are up […]

Read More
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’
Health

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’

It’s been a stellar few months for shares of San Francisco-based biotech company Rigel Pharmaceuticals, which has approved treatments for rheumatology and oncology — as well as potential new drugs in the pipeline. The stock has jumped about 50% in just the last three months, earning it a spot on CNBC’s list of top performing […]

Read More
We’re raising our Eli Lilly price target — what a difference a quarter makes
Health

We’re raising our Eli Lilly price target — what a difference a quarter makes

Eli Lilly shares jumped Thursday after the drugmaker posted a strong third quarter, driven by sales of its popular GLP-1 medications. The company also raised its full-year sales outlook for the second time in a row, inspiring confidence in the trajectory of the franchise. Revenue in the three months ended Sept. 30 jumped 54% year […]

Read More